Journal profile · Hematology
Transfusion Medicine Reviews
ISSN 0887-7963 · eISSN 1532-9496 · W.B. Saunders Ltd · UNITED STATES · Quarterly · Founded 1987
Transfusion Medicine Reviews: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.06; hybrid open access; APC about USD 3,970; median 69 days to acceptance (39 articles, last 24 months); community-reported acceptance: moderate; 41 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Transfusion Medicine Reviews is published by W.B. Saunders Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood groups and transfusion, Blood transfusion and management and Blood donation and transfusion practices, together about 35.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Transfusion Medicine Reviews provides an international forum in the English language for the publication of scholarly work devoted to the various sub-disciplines that comprise Transfusion Medicine including blood donation and processing, immunohematology, laboratory methods, clinical transfusion practice, hemostasis, cellular therapies, and transfusion and public policy. The aim of the journal is to inform clinicians, researchers, patients, and policy makers to the latest advances in our field. We do this primarily through the publication of original research and analytic reviews. Our original research articles must present original scientific experiments or clinical observations. Our reviews aim to give readers a deeper understanding of the knowledge-base of our field through papers that critically assess the existing literature rather than just summarize it. We expect authors to provide expert, unbiased, insightful analysis of their topic. All manuscripts undergo peer review by a minimum of two reviewers. We also aim to alert readers to emerging technologies as well as new applications of basic science to clinical transfusion practice. Our mission is to inform a worldwide readership of the best knowledge in transfusion. Prospective authors should review the Article Types in the Guide for Authors.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Sunny DzikPublisher website
Editorial board by country: none in mainland China; most named United States 19, Canada 10, Australia 6, United Kingdom 4, Saudi Arabia 2 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood groups and transfusionMedicine13.9%
- Blood transfusion and managementMedicine13%
- Blood donation and transfusion practicesBusiness, Management and Accounting8.3%
- Erythrocyte Function and PathophysiologyMedicine6.6%
- Platelet Disorders and TreatmentsMedicine5.9%
- Hemoglobinopathies and Related DisordersMedicine5.3%
- Trauma, Hemostasis, Coagulopathy, ResuscitationMedicine5.2%
- Human auditory perception and evaluationEngineering5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.06LetPub ·
- Impact factor (publisher)
- 3Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- CiteScore (publisher)
- 5.3Publisher website ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 1.13LetPub ·
- h-index
- 65LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 887OpenAlex ·
- 2-year mean citedness
- 1.85OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 51.52%LetPub ·
Volume
- Articles per year
- 16LetPub ·
Articles by year OpenAlex count · 2,430 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 10 | 10 |
| 2025 | 41 | 17 | 99 |
| 2024 | 33 | 16 | 93 |
| 2023 | 45 | 19 | 350 |
| 2022 | 43 | 12 | 249 |
| 2021 | 47 | 13 | 606 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
69 daysMedian, submission to acceptance · P25–P75 45 days – 103 days
- Acceptance to online
- median 5 days (39 articles)
- Submission to online
- median 76 days
- Sample
- 39 articles with submission and acceptance dates (51 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 36 daysPublisher website ·
- Submission to acceptance
- 66 daysPublisher website ·
- Acceptance to publication
- 7 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,970 / EUR 3,710 / GBP 3,180 / JPY 492,400 | — | — | |
| Publisher website | USD 3,910 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Graphical abstract
- Optional
- Cover letter
- Optional
Article types accepted6
- critical analytic reviewsA primary focus of our journal are manuscripts that offer a critical analysis and assessment of the key papers that were previously published on a specific focu…Length not stated
- letters to the editorWe welcome brief Letters to the Editor especially those that present new unpublished data on a focused topic of relevance to our readers.Length not stated
- narrative reviewTransfusion Medicine Reviews is generally not interested in broad narrative reviews, summaries (without analysis) of the prior literature, or scoping reviews un…Length not stated
- opinionTransfusion Medicine Reviews is generally not interested in broad narrative reviews, summaries (without analysis) of the prior literature, or scoping reviews un…Length not stated
- original researchWe seek reports of the results of interventional studies (clinical trials), observational studies, and laboratory research presenting new data.Length not stated
- reviewTransfusion Medicine Reviews seeks four basic categories of manuscripts:1. Original researchWe seek reports of the results of interventional studies (clinical t…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1987
- ISSN
- 0887-7963
- Electronic ISSN
- 1532-9496
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Transfusion Medicine Reviews
What CAS zone is Transfusion Medicine Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Transfusion Medicine Reviews is in Zone 2 of Medicine, and in Zone 2 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Transfusion Medicine Reviews?
The latest impact factor listed by LetPub is 3.06; CiteScore 5.3, h-index 108.
How long does peer review take at Transfusion Medicine Reviews?
Based on the dates recorded on 39 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 69 days (interquartile range 45–103 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Transfusion Medicine Reviews?
According to the journal's author guidelines: Abstract: ≤ 250 words; Graphical abstract: Optional; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Transfusion Medicine Reviews based?
Of the 44 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (19), Canada (10) and Australia (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Transfusion Medicine Reviews?
According to LetPub and DOAJ records, Transfusion Medicine Reviews is indexed in SCIE and Scopus.
Is Transfusion Medicine Reviews open access, and what is the APC?
Transfusion Medicine Reviews is a hybrid journal. For open-access publication: APC about USD 3,970.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .